<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Medical Laboratory</title>
<title_fa>مجله بین المللی علوم آزمایشگاهی</title_fa>
<short_title>IJML</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijml.ssu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-3706</journal_id_issn>
<journal_id_issn_online>2423-3714</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1394</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2015</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<volume>2</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Assessment of Alpha-1 Antitrypsin Deficiency in Patients with Severe Chronic Obstructive Pulmonary Disease</title>
	<subject_fa>ایمنی شناسی</subject_fa>
	<subject>Immunology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;b&gt;Background and Aims:&lt;/b&gt; Chronic obstructive pulmonary disease (COPD) is a kind of pulmonary diseases characterized by chronic obstruction of lung that is in the form of a diffuse narrowing of airways resulting in air flow resistance. Alpha-1 antitrypsin (AAT) deficiency is genetically relatively common risk factor in patients with COPD throughout the world and the exact cause of its prevalence is unknown. We therefore performed a study to determine the frequency of AAT deficiency in patients with severe COPD compared to the healthy controls.&lt;br&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; In this cross-sectional case control study, AAT serum level in 60 patients with severe COPD for whom the history and spirometry test with FEV1&lt;50% had been confirmed based on gold criteria as well as 60 healthy controls, were tested using commercial kit and nephelometry method.&lt;br&gt;
&lt;b&gt;Results:&lt;/b&gt; The lowest serum levels of AAT measured in patients was &lt;0.349 g/l and the highest was 3.099 g/l. These were obtained in healthy subjects as 1.180 g/l and 4.195 g/l respectively. Out of 60 patients, 4 (6.7%) had partial deficiency of AAT (AAT&lt;1 g/l) and 6 (10%) had definite shortage of AAT (AAT&lt;0.5 g/l). In healthy subjects, we did not find any definite and relative lack of AAT. The comparison of results obtained from these two groups indicated a significant difference between frequency of AAT (P=0.001).&lt;br&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Our findings revealed the frequency of AAT deficiency, as a factor involved in COPD disease, to be 10% and can be the reason for the high prevalence and severity of COPD in Zahedan city.&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Alph-1-antitrypsin, COPD, Zahedan</keyword>
	<start_page>112</start_page>
	<end_page>120</end_page>
	<web_url>http://ijml.ssu.ac.ir/browse.php?a_code=A-10-1-23&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Nezarali </first_name>
	<middle_name></middle_name>
	<last_name>Moulaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Internal Medicine Department, Research Centre for Tropical and Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hossein Ali </first_name>
	<middle_name></middle_name>
	<last_name>Khazaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Immunology and Hematology Department, Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Vida</first_name>
	<middle_name></middle_name>
	<last_name>Pejman</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Zahedan University of Medical Sciences, Zahedan, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
